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ABSTRACT 
Purpose: OSA patients effectively treated by and compliant with CPAP occasionally miss a night’s 
treatment. The purpose of this study was to use a real car interactive driving simulator to assess 
the effects of such an occurrence on the next day’s driving, including the extent to which these 
drivers are aware of increased sleepiness.   
Methods: 11 long-term compliant CPAP treated 50-75y male OSA participants completed a 2h 
afternoon, simulated, realistic monotonous drive in an instrumented car, twice, following one night:  
i) normal sleep with CPAP ii) nil CPAP. Drifting out of road lane (‘incidents’), subjective sleepiness 
every 200sec and continuous EEG activities indicative of sleepiness and compensatory effort were 
monitored.   
Results: Withdrawal of CPAP markedly increased sleep disturbance, and led to significantly more 
incidents, a shorter ‘safe’ driving duration, increased alpha and theta EEG power and greater 
subjective sleepiness. However, increased EEG beta activity indicated more compensatory effort 
was being applied. Importantly, under both conditions there was a highly significant correlation 
between subjective and EEG measures of sleepiness, to the extent that participants were well 
aware of the effects of nil CPAP 
Conclusions: Patients should be aware that compliance with treatment every night is crucial for 
safe driving.   
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1. INTRODUCTION 
Patients with obstructive sleep apnoea (OSA), treated by continuous positive air pressure (CPAP), 
have a level of driving performance that is comparable with that of controls [1], and in many 
countries are permitted to drive once successfully treated. However, polysomnographic studies 
have shown that withdrawal of CPAP in compliant users even for one night results in resumption of 
sleep disordered breathing, followed by immediate recovery on restarting treatment [2,3]. Despite 
knowing the importance of treatment, even the most compliant CPAP users report occasionally 
missing treatment for one night, stating reasons such as, ‘have a cold’ or ‘away from home and 
unable to take the machine’. Few studies have assessed this temporary effect on driving ability. 
For safety reasons, no real road driving studies have assessed this effect of CPAP withdrawal, and 
with the few driving simulation studies, only simple simulators have been utilised. These lack 
realism, typically using a replica steering wheel linked to a computer-based tracking task displayed 
on a computer screen. Using such a task, Turkington et al. [4] reported impaired tracking ability 
following CPAP withdrawal, although performance did not fall as low as pre-treatment levels.  
However, the test only lasted 20 min, which is too short a duration to reveal the full effect of 
sleepiness, and does not typify many driving situations, especially as sleepiness only becomes 
particularly evident during monotonous drives beyond 20 min (eg. [5,6]). Moreover, realistic full-
scale interactive driving simulators involving an interactive real car, further add to the realism and, 
arguably, provide more valid data. 
Although some laboratory studies have utilised simple performance measures, such as the PVT, in 
assessing acute CPAP withdrawal effects (eg. [3,7,]), such tests only last around 10 min and are of 
limited comparability with much longer and more realistic periods of driving. Similarly, whilst sleep 
onset findings with the multiple sleep latency test (MSLT) show significant reductions after one 
night of CPAP withdrawal (eg. [8]), this test involves participants lying down in a darkened room 
and encouraged to go to sleep, which clearly contrasts with the driver who has to stay awake 
under somewhat more stimulating conditions.   
The present study had two aims. First, to assess the extent to which sustained driving performance 
in a full size interactive and realistic driving simulator can be maintained following one night of 
CPAP withdrawal in otherwise successfully treated participants having OSA. The second aim 
comes from evidence that sufferers with OSA may have a distorted self awareness of sleepiness 
when driving, at least before treatment [9]. In the light of this, a novel aspect of this study is to 
determine the extent to which those who have been successfully treated by CPAP might 
underestimate sleepiness whilst driving, after a night without CPAP. 
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2. METHOD 
2.1 Participants 
OSA participants were recruited from a regional sleep apnoea patients association, all of whom 
had been undergoing CPAP treatment for an average of 7.8y.  All were men aged between 50 and 
75 years, had Epworth sleepiness scale (ESS) [10] scores <10 and drove >3h per week. Initial 
selection was by structured interview, including questions relating to health, medication, sleep, 
driving and OSA, as well as caffeine intake. This was followed by measurements of height, weight 
and percentage body fat calculated using a body composition analyzer TBF-300 (TANITA 
Corporation). They were then given a familiarisation drive.  This study was part of a larger 
investigation involving sleep restriction in patients and healthy controls [11]. Participants were 
asked if they would also be prepared to go without CPAP for another night so that we could make 
further comparisons.  Eleven agreed to participate in this component of the study.  Further details 
of these 11 participants can be seen in Table 1.  For all experimental phases (see below), 
participants were collected from and returned to home via taxi and advised not to drive or 
undertake any potentially hazardous activities until they had a full night’s sleep with CPAP. They 
were given a small cash gift on completion.  The study met with the full approval of the University’s 
Ethical Committee.   
2.2 Design & Procedure 
The study consisted of two conditions:  
1. a normal night’s sleep with CPAP 
2. a night’s sleep without CPAP 
To ensure compliance with sleep instructions, participants wore wrist actimeters (Cambridge 
Neurotechnology, UK) for three nights prior to each experimental day, when they also kept daily 
logs of: estimated sleep onset, and morning wakening and rising times.  As well as sleep duration, 
sleep quality was assessed by calculating sleep disturbance index (SDI) 
SDI = actual awake time (min) / assumed total sleep (min) 
No alcohol was consumed 36h prior to each drive, and nil caffeine after 18:00h the evening before.  
Participants refrained from eating after 10:00h on the morning of the drive, and had consumed only 
a light breakfast. On arrival at the laboratory, at 13:00h, they were given a light lunch of two cheese 
rolls and a glass of water. Actimeters were downloaded to verify that they had complied with the 
previous night’s sleep requirements. At 13:15h electrodes were applied and they went to the 
simulator (see below) at 13:50h, to be given 10 min to settle into the car, the 2h drive began at 
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14:00h. Participants were instructed to drive in the left hand lane (unless overtaking) at a speed 
appropriate for the road and where full control of the vehicle could be maintained. During the drive 
the investigator remained in the room, out of sight, but there was no communication once the drive 
had begun.  
2.3 Apparatus 
2.3.1 Car Simulator – This comprises an immobile car with a full-size, interactive, computer 
generated road projection of a dull monotonous dual carriageway, each with two lanes. The image 
is projected onto a 2.0m x 1.5m screen, located 2.3m from the car windscreen. The road has a 
hard shoulder and simulated auditory ‘rumble strips’ (incorporated into white lane markings) either 
side of the carriageway, with long straight sections followed by gradual bends. ‘Crash barriers’ are 
located either side, beyond the rumble strips. Slow moving vehicles are met occasionally, which 
have to be overtaken. Lane drifting is the most common manifestation of sleepy driving; occasions 
where all four wheels of the car cross the left rumble strip or right side lane line are identified as a 
driving ‘incident’ (in the UK driving is on the left side of the road). Split-screen video footage of the 
roadway and driver’s face (filmed by an unobtrusive infrared camera) enable the cause of the 
incident to be determined. Those due to sleepiness (e.g. eye closure, eyes rolling upwards or 
vacant staring ahead) are logged as a ‘sleep-related incident’. As a further check for the latter, the 
electroencephalogram (EEG) and electrooculogram (EOG - see below) are examined respectively 
for alpha/theta intrusions and confirmation of any ‘eye rolling’. Non-sleep related incidents (driver 
distraction, fidgeting or looking around) are excluded.  
2.3.2 Subjective Sleepiness – Every 200s during the drive, participants were verbally prompted by 
the computer system to report their subjective sleepiness, and their numerical response was based 
on the 9-point Karolinska Sleepiness Scale (KSS): 1=extremely alert, 2=very alert, 3=alert, 
4=rather alert, 5=neither alert nor sleepy, 6=some signs of sleepiness, 7=sleepy, no effort to stay 
awake, 8=sleepy, some effort to stay awake, 9=very sleepy, great effort to keep awake, fighting 
sleep. The scale was located on the car’s dashboard and continuously visible to the driver. This 
prompting and its response quickly became routine for the driver.   
2.3.3 EEG and EOG - Electrodes were attached for two channels of EEG, with inter-electrode 
distances carefully maintained by using the ‘10-20 EEG montage’ (main channel C3-A1, backup 
channel C4-A2), and there were two EOG channels (electrodes 1cm lateral to and below left outer 
canthus and 1cm lateral to and above right outer canthus; both referred to the centre of the 
forehead). EEGs and EOGs were recorded using “Embla” (Flaga Medica Devices, Iceland) and 
spectrally analysed using “Somnologica” (Flaga) in 4s epochs. EEG low and high band-pass 
filtering at >20Hz and <4Hz removed slow eye movements and muscle artefacts. In these 
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circumstances, greater EEG power in the alpha (8-11Hz) and theta (4-7Hz) ranges reflect 
increased sleepiness [12-14], whereas increased beta activity (13-20Hz) indicates increased 
arousal, anxiety and mental effort, suggestive of trying to stay awake [15-17]. EEG power in 4-11 
Hz (theta+alpha) was averaged in one minute epochs, as was beta activity (13-20Hz). To 
accommodate for individual differences in EEG power, and to allow comparisons between 
conditions, each individual’s power in these ranges was standardised for each condition, by taking 
the difference between each minute’s epoch and the individual’s mean value over the first 30min of 
the normal sleep with CPAP condition, then divide this by the standard deviation around the mean 
of that 30min of data [18]. This can mean that when 4-11Hz power is particularly low, values may 
appear to be negative (as was the case with initial driving after normal sleep – see Figures 4 and 
6). 
 2.4 Statistical Analyses 
Repeated measures analysis of variance (ANOVA) were utilised, with two within subject factors: 
Condition – (two levels: normal sleep and CPAP withdrawal); Duration of driving (four levels:  0-30 
min, 30-60min, 60-90min and 90-120min). Where appropriate square root transformations 
corrected for skewed driving incident raw data. Repeated measures t tests were applied to other 
overall group differences.  
3. RESULTS 
3.1 Total sleep time and SDI.  There was no significant difference between sleep duration 
between the two conditions.  Withdrawal of CPAP significantly increased SDI from 7.9 after a 
normal night’s sleep to 13.8 without CPAP [t(10) = 3.5, p <0.05 – two tail].  
3.2 Driving incidents (Figure 1) – Following CPAP withdrawal there were significantly more 
incidents [F(1,20) = 12.33, p< 0.05] and, as might be expected there was a significant rise in 
incidents over the duration of the drive, over both conditions [F(3,30) = 4.75, p < 0.05], but no 
significant interaction.  
3.3 Time to first incident (‘safe driving time’) (Figure 2) - After normal sleep participants drove 
for an average of 90min (s.e. 9min). Following CPAP withdrawal this decreased to 50min (11min) 
resulting in a significant difference between conditions [t(10) = 3.8, p < 0.05]  
3.3 Subjective Sleepiness – KSS (Figure 3 - mean changes per 200 sec).  When data were 
collapsed into 30 min epochs there was a significant effect of condition [F(1,10) = 24.12, p < 0.05], 
and duration of drive [F (3,30) = 69.03, p <0.05]. The interaction between condition and drive 
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duration was also significant [F(3,30) = 5.03, p< 0.05], with CPAP withdrawal having a greater 
effect during the first hour. 
3.4 EEG – Theta + Alpha Power (Figure 4 – mean values per min).  There was no significant 
difference between conditions when data were collapsed into 30 min epochs [F(1,10) = 1.82, p = 
0.207], but there was a significant overall effect of drive duration [F(3.30) = 6.03, p ,0.05].  
Interestingly, though, just before the mean onset of the first driving incident under CPAP 
withdrawal, between minutes 45-50, there was a surge in this power compared with normal sleep; 
a one tail t-test  [t(10)= 1.87, p<0.05 – one tail].         
3.5 EEG - Beta Power (Figure 5 – mean values per min). When data were collapsed into 30 min 
epochs, there was a significant between conditions effect [F(1,10) = 4.0, p = 0.05] indicating that 
participants were applying more compensatory effort after CPAP withdrawal. There was also an 
overall significant effect of drive duration [F(3,30) = 3.56, p < 0.05], but no significant interaction. 
3.6 Correlation between Theta + Alpha Power and KSS (Figure 6). Figure 6 makes the direct 
comparison for CPAP withdrawal, and when these EEG data are collapsed into 200sec epochs 
and correlated with KSS data, the outcome was indeed highly significant [r=0.88, df 34; p<0.000], 
and likewise for the normal sleep condition [r=0.87, df 34; p<0.000].   
4. DISCUSSION 
Our participants experienced significantly more sleep disturbance during CPAP withdrawal, despite 
a comparable total sleep times. This indicates a resumption of sleep disordered breathing; a 
finding in line with those from CPAP withdrawal studies using full PSG recordings [2,3].   
One night without CPAP significantly worsened sleepiness and driving performance in long term 
treated compliant CPAP users.  A significant reduction (by 40 min) in ‘safe driving time’ was also 
evident after CPAP withdrawal, with the first incident being portended by a marked rise in 
alpha+theta activity 5 min beforehand.  However, participants remained subjectively quite aware of 
their increased sleepiness (as determined objectively by EEG). Moreover, under both sleep 
conditions there was a highly significant association between these two measures of sleepiness.  
This level of self-awareness of increasing sleepiness when driving is similar to what we have found 
with a group of healthy drivers of a similar age (mean age 66.6y [52–74y]) having undergone sleep 
restriction [11], and in young male adult drivers [19,20]. 
The incidents occurring on the simulator are indicative of dangerous driving, which is not to say 
that a collision is imminent or that an incident would occur at this time on a real road, as the more 
evident dangers of real driving would probably have enabled our participants to have driven safely 
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for longer on real roads. Nevertheless there is good evidence that simulators such as ours do 
reflect real driving conditions [21], and it remains likely that following CPAP withdrawal driving 
performance would be impaired because of the obvious increase in daytime sleepiness.   
Our study has shortcomings especially as participant selection may have been biased, as they 
were also self-selected from the original group of 19. All of the latter had been asked if they had 
ever missed a nights treatment, and all those reporting ‘yes’ to this question happened to decline to 
participate in this extra component of CPAP withdrawal and were absent from the 11 volunteers. It 
is a reoccurring problem in this type of study, as Yang et al [2] noted “individuals who are compliant 
CPAP users may be reluctant to volunteer for this type of research if they have previously 
experienced marked negative symptoms with CPAP withdrawal.” The withdrawal of the CPAP 
treatment may have influenced the participant’s subjective reports of sleepiness. An alternative 
approach would have been to provide sham (non therapeutic) CPAP so that participants would not 
be aware that they had not received treatment that night. The current protocol was designed to 
represent occasions when patients may miss a nights treatment due to reasons such as being 
away from home and not taking the machine with them, on such occasions patients would be 
aware that they had not used the treatment and as such withdrawal of treatment in our study 
allows us to assess the impact this would have.  
Ours was a study designed to highlight the risk of missing one night’s CPAP treatment in compliant 
users. However many OSA patients use their CPAP for only part of a night, and we have yet to 
determine to what extent this might impact on driving ability.  
OSA patients need to know that even if they are generally fully compliant with treatment, CPAP 
withdrawal is likely to increase sleepiness and impair driving to a greater degree than might be 
anticipated, especially on monotonous roads and during the afternoon bi-circadian trough.  
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Table 1   Participant characteristics - mean and standard error 
Fig. 1 Driving incidents in 30 minute epochs - mean and standard error. There was a significant 
effect of CPAP withdrawal.  
Fig. 2 Number of minutes until first driving incident - mean and standard error. There was a 
significant effect of CPAP withdrawal.  
Fig. 3 Mean KSS scores every 200 seconds. There were significant effects for between conditions, 
and significant interaction with time on task. 
Fig. 4 Mean standardised theta+alpha (4-11Hz) EEG power in 1 min epoch (smoothed by 3 point 
running average). There was a significant effect of drive duration, although no significant overall 
effect of condition. 
Fig. 5 Mean standardised beta (13-20Hz) EEG power in 1 min epochs (smoothed by 3 point 
running average). There was a significant effect of condition with more beta power following CPAP 
withdrawal.   
Fig. 6 Comparison of KSS with standardised EEG theta + alpha following CPAP withdrawal. The 
two measures are significantly correlated.   
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Table 1  
 
N=11 Mean 
AGE (y) 65.6 (2.3) 
BMI 33.1 (1.8) 
% FAT 32.5 (2.1)  
ESS 5.2 (0.7) 
USUAL SLEEP  (min  
actimeter) 
465 (3.6) 
SLEEP baseline (min 
actimeter)  
436 (4.0) 
SLEEP CPAP withdrawal 
(min actimeter) 
403 (3.6) 
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Figure 4 
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